John E. Bishop, SVP, Pharmaceutical Scie at Momenta Pharma, holds 0.00 shares in Forma Therapeutics Holdings (Ticker: FMTX), holds 93.52K shares in Momenta Pharma (Ticker: MNTA), holds ― shares in Lyra Therapeutics (Ticker: LYRA).
What is the percentage of profitable transactions made by John E. Bishop?
The percentage of profitable transactions made by John E. Bishop is 50%.
What is the average return per transaction made by John E. Bishop?
The average return per transaction made by John E. Bishop is -7.10%.
What stocks does John E. Bishop hold?
John E. Bishop holds: MNTA, FMTX, LYRA stocks.
What was John E. Bishop’s latest transaction?
John E. Bishop latest transaction was an Uninformative Sell of ―.
What was John E. Bishop's most profitable transaction?
John E. Bishop’s most profitable transaction was an Informative Sell of MNTA stock on August 30, 2012. The return on the trade was 0.90%.
What is John E. Bishop's role in Momenta Pharma?
John E. Bishop's role in Momenta Pharma is SVP, Pharmaceutical Scie.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.